A machine learning-based megakaryocyte identification system uncovers…
Scientists mapped where platelet-making cells live in the brain and heart, revealing they may help guide early brain development—opening new questions about their role in nervous system health.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Multimodal predictions of end stage chronic kidney disease from…
A genetic variant affecting kidney filtering cells predicts who might develop kidney failure five years early, potentially helping doctors identify at-risk people across all ancestry groups.
Underserved or high-risk populationsExtramedullary AML
Leukemia patients with cancer spreading outside bone marrow face much shorter survival, highlighting why genetic testing and tailored treatment strategies matter for this aggressive form.
Near-term implementable findingClinical utilisation and survival correlation of blood-based liquid…
Cancer-fighting DNA circulating in blood strongly predicts sarcoma recurrence, offering a practical tool for closer monitoring when tissue biopsies are difficult to repeat.
Underserved or high-risk populationsWWOX in brain development and disease
Gene therapy rescues seizures and survival in mice with rare WWOX epilepsy, establishing a clear path toward testing this approach in children with this devastating condition.